- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01544049
Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
September 11, 2018 updated by: Elizabeth Swisher, University of Washington
Patients Salpingectomy as a Method of Ovarian Cancer Prevention: A Descriptive Study
The purpose of this study is to better understand why women choose to have their fallopian tubes removed as a method for ovarian cancer prevention.
This will be done through a paper questionnaire and phone interviews.
The investigators hope to gain information that will allow us to better counsel women about ovarian cancer prevention.
Study Overview
Status
Completed
Conditions
Detailed Description
Women will be found eligible for this study after an eligibility questionnaire given over the phone.
If one is found eligible, she will be sent a consent and paper survey to fill out and send back to the research coordinator.
Once that is completed, she will be given a phone interview in order answer additional questions of interest.
Lastly, the study participant will be contacted once a year over the phone to obtain follow-up information.
Study Type
Observational
Enrollment (Actual)
24
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women who have had their fallopian tubes removed as a method of ovarian cancer prevention.
Description
Inclusion Criteria:
- Female of at least 18 years of age
- Must speak English fluently
- Have had fallopian tubes removed as a method of ovarian cancer prevention
Exclusion Criteria:
- Males
- Females under the age of 18
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Fallopian tube removal
Women who have had one or both fallopian tube(s) removed as method of ovarian cancer prevention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Describe subject experience in undergoing Salpingectomy as a means of riks reduction
Time Frame: At conclusion of study
|
Subjects will provide information on their reason for choosing salpingectomy and the process they went through in undergoing this procedure
|
At conclusion of study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Elizabeth Swisher, MD, University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2011
Primary Completion (Actual)
September 4, 2018
Study Completion (Actual)
September 4, 2018
Study Registration Dates
First Submitted
February 28, 2012
First Submitted That Met QC Criteria
March 2, 2012
First Posted (Estimate)
March 5, 2012
Study Record Updates
Last Update Posted (Actual)
September 12, 2018
Last Update Submitted That Met QC Criteria
September 11, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neoplasms by Histologic Type
- Neoplasms
- Urogenital Neoplasms
- Neoplasms by Site
- Carcinoma
- Neoplasms, Glandular and Epithelial
- Genital Neoplasms, Female
- Endocrine System Diseases
- Ovarian Diseases
- Adnexal Diseases
- Gonadal Disorders
- Endocrine Gland Neoplasms
- Ovarian Neoplasms
- Carcinoma, Ovarian Epithelial
Other Study ID Numbers
- STUDY00000276
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.